TEST BANK
LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
KARA SEALOCK
4th Edition
TEST BANK
, lOMoAR cPSD| 3013804
lOMoAR cPSD| 3013804
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
ANS: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to sw
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
ANS: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and h
of possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
ANS: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which st
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
ANS: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable o
instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatmen
and would be difficult to measure.
DIF: Cognitive Level: Application
, lOMoAR cPSD| 3013804
6. The nurse is working during a very busy night shift, and the health care provider has just given the nurs
the telephone, but the nurse does not recall the route. What is the best way for the nurse to avoid medic
a. Recopy the order neatly on the order sheet, with the most common route indicated
b. Consult with the pharmacist for clarification about the most common route
c. Call the health care provider to clarify the route of administration
d. Withhold the drug until the health care provider visits the patient
ANS: C
If a medication order does not include the route, the nurse must ask the health care provider to clarify it
administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
7. Which constitutes the traditional Five Rights of medication administration?
a. Right drug, right route, right dose, right time, and right patient
b. Right drug, the right effect, the right route, the right time, and the right patient
c. Right patient, right strength, right diagnosis, right drug, and right route
d. Right patient, right diagnosis, right drug, right route, and right time
ANS: A
The traditional Five Rights of medication administration were considered to be Right drug, Right route
Right patient. Right effect, right strength, and right diagnosis are not part of the traditional Five Rights
DIF: Cognitive Level: Comprehension
8. What correctly describes the nursing process?
a. Diagnosing, planning, assessing, implementing, and finally evaluating
b. Assessing, then diagnosing, implementing, and ending with evaluating
c. A linear direction that begins with assessing and continues through diagnosing,
planning, and finally implementing
d. An ongoing process that begins with assessing and continues with diagnosing,
planning, implementing, and evaluating
ANS: D
The nursing process is an ongoing, flexible, adaptable, and adjustable five-step process that begins with
through diagnosing, planning, implementing, and finally evaluating, which may then lead back to any o
DIF: Cognitive Level: Application
9. When the nurse is considering the timing of a drug dose, which is most important to assess?
a. The patient’s identification
b. The patient’s weight
c. The patient’s last meal
d. Any drug or food allergies
ANS: C
The pharmacokinetic and pharmacodynamic properties of the drug need to be assessed with regard to a
compatibility issues. The patient’s identification, weight, and drug or food allergies are not affected by
DIF: Cognitive Level: Application
10. The nurse is writing nursing diagnoses for a plan of care. Which reflects the correct format for her nurs
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements such as “I’m upset about having to give myself shots”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to give myself shots”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. The only complete answer is “Anxiet
, lOMoAR cPSD| 3013804
Chapter 02: Pharmacological Principles
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. A fpatient fis freceiving ftwo fdifferent fdrugs, fwhich, fat ftheir fcurrent fdose fforms fand fdosages, fare fboth
fcirculation fin fidentical famounts. fWhich fterm fbest fdenotes fthat fthe fdrugs fhave fthe fsame fabsorption
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: f D
Two fdrugs fabsorbed finto fthe fcirculation fat fthe fsame famount f(in fspecific fdosage fforms) fhave fthe
fthey fare fbioequivalent. f“Equivalent” fis fincorrect fbecause fthe fterm f“bioavailability” fis fused fto f
fabsorption.
“Synergistic” fis fincorrect fbecause fthis fterm frefers fto ftwo fdrugs fgiven ftogether fwhose fresulting feff
fof fthe feffects fof feach fdrug fgiven falone. f“Compatible” fis fincorrect fbecause fthis fterm fis fa fgeneral
ftwo fsubstances fdo fnot fhave fa fchemical freaction fwhen fmixed f(or fgiven, fin fthe fcase fof fdrugs) ftoge
DIF: Cognitive fLevel: fComprehension
2. A fpatient fis freceiving fmedication fvia fintravenous finjection. fWhich finformation fshould fthe fnurse fpr
a. The fmedication fwill fcause ffewer fadverse feffects fwhen fgiven fintravenously.
b. The fmedication fwill fbe fabsorbed fslowly finto fthe ftissues fover ftime.
c. The fmedication’s faction fwill fbegin ffaster fwhen fgiven fintravenously.
d. Most fof fthe fdrug fis finactivated fby fthe fliver fbefore fit freaches fthe ftarget farea.
ANS: f C
Intravenous finjections fare fthe ffastest froute fof fabsorption. fThe fintravenous froute fdoes fnot faffect fthe
feffects, fthe fintravenous froute fis fnot fa fslow froute fof fabsorption, fand fthe fintravenous froute fdoes fno
fdrug fby fthe fliver fbefore fit freaches fthe ftarget farea.
DIF: Cognitive fLevel: fComprehension
3. Which fis ftrue fregarding fparenteral fdrugs?
a. They fbypass fthe ffirst-pass feffect.
b. They fdecrease fblood fflow fto fthe fstomach.
c. They fare faltered fby fthe fpresence fof ffood fin fthe fstomach.
d. They fexert ftheir feffects fwhile fcirculating fin fthe fbloodstream.
ANS: f A
Drugs fgiven fby fthe fparenteral froute fbypass fthe ffirst-pass feffect, fbut fthey fstill fmust fbe fabsorbed finto
fthey fcan fexert ftheir feffects. fEnteral fdrugs f(drugs ftaken forally), fnot fparenteral fdrugs, fdecrease fbloo
fare f altered fby fthe fpresence fof ffood fin fthe fstomach. fParenteral fdrugs fmust fbe fabsorbed finto fcells f
fcirculation fbefore fthey fcan fexert ftheir feffects; fthey fdo fnot fexert ftheir feffects fwhile fcirculating fin ft
DIF: Cognitive fLevel: fAnalysis
4. A fdrug’s fhalf-life fis fbest fdefined fas
a. The ftime fit ftakes ffor fthe fdrug fto felicit fhalf fits ftherapeutic fresponse.
b. The ftime fit ftakes fone-half fof fthe foriginal famount fof fa fdrug fto freach fthe
ftarget fcells.
c. The ftime fit ftakes fone-half fof fthe foriginal famount fof fa fdrug fto fbe fremoved
ffrom fthe fbody.
d. The ftime fit ftakes fone-half fof fthe foriginal famount fof fa fdrug fto fbe fabsorbed
finto fthe fcirculation.
ANS: f C
LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE
KARA SEALOCK
4th Edition
TEST BANK
, lOMoAR cPSD| 3013804
lOMoAR cPSD| 3013804
Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
ANS: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about
heath conditions and life processes or vulnerability for that response.
DIF: Cognitive Level: Knowledge
2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to sw
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
ANS: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n
DIF: Cognitive Level: Application
3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and h
of possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
ANS: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursing
illustrated by this example.
DIF: Cognitive Level: Application
4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which st
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
ANS: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable o
instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatmen
and would be difficult to measure.
DIF: Cognitive Level: Application
, lOMoAR cPSD| 3013804
6. The nurse is working during a very busy night shift, and the health care provider has just given the nurs
the telephone, but the nurse does not recall the route. What is the best way for the nurse to avoid medic
a. Recopy the order neatly on the order sheet, with the most common route indicated
b. Consult with the pharmacist for clarification about the most common route
c. Call the health care provider to clarify the route of administration
d. Withhold the drug until the health care provider visits the patient
ANS: C
If a medication order does not include the route, the nurse must ask the health care provider to clarify it
administration.
DIF: Cognitive Level: Application | Cognitive Level: Analysis
7. Which constitutes the traditional Five Rights of medication administration?
a. Right drug, right route, right dose, right time, and right patient
b. Right drug, the right effect, the right route, the right time, and the right patient
c. Right patient, right strength, right diagnosis, right drug, and right route
d. Right patient, right diagnosis, right drug, right route, and right time
ANS: A
The traditional Five Rights of medication administration were considered to be Right drug, Right route
Right patient. Right effect, right strength, and right diagnosis are not part of the traditional Five Rights
DIF: Cognitive Level: Comprehension
8. What correctly describes the nursing process?
a. Diagnosing, planning, assessing, implementing, and finally evaluating
b. Assessing, then diagnosing, implementing, and ending with evaluating
c. A linear direction that begins with assessing and continues through diagnosing,
planning, and finally implementing
d. An ongoing process that begins with assessing and continues with diagnosing,
planning, implementing, and evaluating
ANS: D
The nursing process is an ongoing, flexible, adaptable, and adjustable five-step process that begins with
through diagnosing, planning, implementing, and finally evaluating, which may then lead back to any o
DIF: Cognitive Level: Application
9. When the nurse is considering the timing of a drug dose, which is most important to assess?
a. The patient’s identification
b. The patient’s weight
c. The patient’s last meal
d. Any drug or food allergies
ANS: C
The pharmacokinetic and pharmacodynamic properties of the drug need to be assessed with regard to a
compatibility issues. The patient’s identification, weight, and drug or food allergies are not affected by
DIF: Cognitive Level: Application
10. The nurse is writing nursing diagnoses for a plan of care. Which reflects the correct format for her nurs
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements such as “I’m upset about having to give myself shots”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to give myself shots”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. The only complete answer is “Anxiet
, lOMoAR cPSD| 3013804
Chapter 02: Pharmacological Principles
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
MULTIPLE CHOICE
1. A fpatient fis freceiving ftwo fdifferent fdrugs, fwhich, fat ftheir fcurrent fdose fforms fand fdosages, fare fboth
fcirculation fin fidentical famounts. fWhich fterm fbest fdenotes fthat fthe fdrugs fhave fthe fsame fabsorption
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: f D
Two fdrugs fabsorbed finto fthe fcirculation fat fthe fsame famount f(in fspecific fdosage fforms) fhave fthe
fthey fare fbioequivalent. f“Equivalent” fis fincorrect fbecause fthe fterm f“bioavailability” fis fused fto f
fabsorption.
“Synergistic” fis fincorrect fbecause fthis fterm frefers fto ftwo fdrugs fgiven ftogether fwhose fresulting feff
fof fthe feffects fof feach fdrug fgiven falone. f“Compatible” fis fincorrect fbecause fthis fterm fis fa fgeneral
ftwo fsubstances fdo fnot fhave fa fchemical freaction fwhen fmixed f(or fgiven, fin fthe fcase fof fdrugs) ftoge
DIF: Cognitive fLevel: fComprehension
2. A fpatient fis freceiving fmedication fvia fintravenous finjection. fWhich finformation fshould fthe fnurse fpr
a. The fmedication fwill fcause ffewer fadverse feffects fwhen fgiven fintravenously.
b. The fmedication fwill fbe fabsorbed fslowly finto fthe ftissues fover ftime.
c. The fmedication’s faction fwill fbegin ffaster fwhen fgiven fintravenously.
d. Most fof fthe fdrug fis finactivated fby fthe fliver fbefore fit freaches fthe ftarget farea.
ANS: f C
Intravenous finjections fare fthe ffastest froute fof fabsorption. fThe fintravenous froute fdoes fnot faffect fthe
feffects, fthe fintravenous froute fis fnot fa fslow froute fof fabsorption, fand fthe fintravenous froute fdoes fno
fdrug fby fthe fliver fbefore fit freaches fthe ftarget farea.
DIF: Cognitive fLevel: fComprehension
3. Which fis ftrue fregarding fparenteral fdrugs?
a. They fbypass fthe ffirst-pass feffect.
b. They fdecrease fblood fflow fto fthe fstomach.
c. They fare faltered fby fthe fpresence fof ffood fin fthe fstomach.
d. They fexert ftheir feffects fwhile fcirculating fin fthe fbloodstream.
ANS: f A
Drugs fgiven fby fthe fparenteral froute fbypass fthe ffirst-pass feffect, fbut fthey fstill fmust fbe fabsorbed finto
fthey fcan fexert ftheir feffects. fEnteral fdrugs f(drugs ftaken forally), fnot fparenteral fdrugs, fdecrease fbloo
fare f altered fby fthe fpresence fof ffood fin fthe fstomach. fParenteral fdrugs fmust fbe fabsorbed finto fcells f
fcirculation fbefore fthey fcan fexert ftheir feffects; fthey fdo fnot fexert ftheir feffects fwhile fcirculating fin ft
DIF: Cognitive fLevel: fAnalysis
4. A fdrug’s fhalf-life fis fbest fdefined fas
a. The ftime fit ftakes ffor fthe fdrug fto felicit fhalf fits ftherapeutic fresponse.
b. The ftime fit ftakes fone-half fof fthe foriginal famount fof fa fdrug fto freach fthe
ftarget fcells.
c. The ftime fit ftakes fone-half fof fthe foriginal famount fof fa fdrug fto fbe fremoved
ffrom fthe fbody.
d. The ftime fit ftakes fone-half fof fthe foriginal famount fof fa fdrug fto fbe fabsorbed
finto fthe fcirculation.
ANS: f C
